Nucleic acids involved in the responder phenotype and applications thereof
CA 2311166 C · Owner: Kispert, Andreas · Inventors: Koschorz, Birgit; Kispert, Andreas; Herrmann, Bernhard
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to nucleic acid molecules encoding expression products involved in the Responder function which contributes to the , phenomenon of transmission ratio distortion. The present invention also relates to regulatory regions of the genes corresponding to said nucleic acid molecules. The present invention further relates to recombinant DNA molecules and vectors comprising said nucleic acid molecules and/or regulatory regions as well as to host cells transformed therewith. Additionally the present , invention relates to transgenic animals comprising said nucleic acid , molecules recombinant DNA molecules or vectors stably integrated into their genome. The various …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 18, 1998 and granted June 19, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 18, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 18, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.